Oncolytics Biotech (ONCY) Tops Q3 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Ennis (EBF) Reports In-Line Q1 EPS
• SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters